Baird Medical Enters South Korea Market through Strategic Distribution Partnership with ALLIS MED
Key Highlights
- ➤Baird Medical (BDMD) partners with ALLIS MED to enter South Korea
- ➤ALLIS MED will manage regulatory submissions and Ministry of Food and Drug Safety interactions
- ➤ALLIS MED becomes exclusive South Korea distributor after product certification
- ➤Partnership introduces microwave ablation technology beyond South Korea’s radiofrequency-based procedures
- ➤Baird Medical submitted its Irreversible Electroporation System for FDA 510(k) and CE review
Expert Statements
Haimei Wu, Chairwoman and CEO of Baird Medical
“Our entry into the South Korea market represents another important milestone in our ongoing global expansion strategy, while further strengthening our footprint in Asia.”
Haimei Wu, Chairwoman and CEO of Baird Medical
“Thus far in 2026, we have made inroads into multiple new markets, including Argentina, Egypt, Pakistan and Vietnam, while taking steps to strengthen our leadership position in the PRC and significantly expanding our commercial presence in the United States.”
Haimei Wu, Chairwoman and CEO of Baird Medical
“These initiatives have helped to diversify our revenue base and create a stronger, more stable, global foundation for long-term growth.”
Haimei Wu, Chairwoman and CEO of Baird Medical
“These achievements, coupled with recent technological and regulatory advancements including the FDA 510(k) and CE submissions for our Irreversible Electroporation System, position us well to continue our global market expansion efforts as we prepare to enter 2027.”
NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), announced that it has entered into a strategic distribution partnership with ALLIS MED, a medical device distributor focused on the sale of surgical products and technologies to university hospitals and community medical centers.
Under the agreement, ALLIS MED will serve as Baird Medical’s Korea License Holder, and will manage regulatory submissions and interaction with the Ministry of Food and Drug Safety. Following receipt of product certification, ALLIS MED will become the exclusive distributor of Baird Medical’s products in South Korea.
Get started
Create a free account to read the full story.